OCA at 12:01, 1 February 2024

OCA — Thu, 01 Feb 2024 12:01:55 GMT

←Older revision		Revision as of 12:01, 1 February 2024
Line 1:		Line 1:

-	====	+	==50S Deinococcus radiodurans ribosome bounded with mycinamicin IV==
-	<StructureSection load='7a18' size='340' side='right'caption='[[7a18]]' scene=''>	+	<StructureSection load='7a18' size='340' side='right'caption='[[7a18]], [[Resolution\|resolution]] 3.40Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[7a18]] is a 10 chain structure with sequence from [https://en.wikipedia.org/wiki/Deinococcus_radiodurans_R1 Deinococcus radiodurans R1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7A18 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7A18 FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7a18 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7a18 OCA], [https://pdbe.org/7a18 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7a18 RCSB], [https://www.ebi.ac.uk/pdbsum/7a18 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7a18 ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 3.4Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MIV:MYCINAMICIN+IV'>MIV</scene>, <scene name='pdbligand=SPD:SPERMIDINE'>SPD</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7a18 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7a18 OCA], [https://pdbe.org/7a18 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7a18 RCSB], [https://www.ebi.ac.uk/pdbsum/7a18 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7a18 ProSAT]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/RL2_DEIRA RL2_DEIRA] One of the primary rRNA binding proteins. Required for association of the 30S and 50S subunits to form the 70S ribosome, for tRNA binding and peptide bond formation. It has been suggested to have peptidyltransferase activity; this is somewhat controversial. Makes several contacts with the 16S rRNA in the 70S ribosome (By similarity).[HAMAP-Rule:MF_01320_B]
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Macrolides have been effective clinical antibiotics for over 70 years. They inhibit protein biosynthesis in bacterial pathogens by narrowing the nascent protein exit tunnel in the ribosome. The macrolide class of natural products consist of a macrolactone ring linked to one or more sugar molecules. Most of the macrolides used currently are semi-synthetic erythromycin derivatives, composed of a 14- or 15-membered macrolactone ring. Rapidly emerging resistance in bacterial pathogens is among the most urgent global health challenges, which render many antibiotics ineffective, including next-generation macrolides. To address this threat and advance a longer-term plan for developing new antibiotics, we demonstrate how 16-membered macrolides overcome erythromycin resistance in clinically isolated Staphylococcus aureus strains. By determining the structures of complexes of the large ribosomal subunit of Deinococcus radiodurans (D50S) with these 16-membered selected macrolides, and performing anti-microbial studies, we identified resistance mechanisms they may overcome. This new information provides important insights toward the rational design of therapeutics that are effective against drug resistant human pathogens.
		+
		+	Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida.,Breiner-Goldstein E, Eyal Z, Matzov D, Halfon Y, Cimicata G, Baum M, Rokney A, Ezernitchi AV, Lowell AN, Schmidt JJ, Rozenberg H, Zimmerman E, Bashan A, Valinsky L, Anzai Y, Sherman DH, Yonath A Nucleic Acids Res. 2021 Sep 20;49(16):9560-9573. doi: 10.1093/nar/gkab684. PMID:34417608<ref>PMID:34417608</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 7a18" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Ribosome 3D structures\|Ribosome 3D structures]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Deinococcus radiodurans R1]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Z~~-disk~~]]	+	[[Category: Bashan A]]
		+	[[Category: Breiner E]]
		+	[[Category: Cimicata G]]
		+	[[Category: Eyal Z]]
		+	[[Category: Halfon Y]]
		+	[[Category: Matzov D]]
		+	[[Category: Rozenberg H]]
		+	[[Category: Yonath A]]
		+	[[Category: Zimmerman E]]

OCA at 05:26, 6 October 2021

OCA — Wed, 06 Oct 2021 05:26:50 GMT

←Older revision		Revision as of 05:26, 6 October 2021
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 7a18 ~~is ON HOLD~~	+	====
-		+	<StructureSection load='7a18' size='340' side='right'caption='[[7a18]]' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7a18 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7a18 OCA], [https://pdbe.org/7a18 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7a18 RCSB], [https://www.ebi.ac.uk/pdbsum/7a18 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7a18 ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Z-disk]]

OCA: Protected "7a18" [edit=sysop:move=sysop]

OCA — Wed, 19 Aug 2020 04:38:30 GMT

Protected "7a18" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:38, 19 August 2020

OCA: New page: '''Unreleased structure''' The entry 7a18 is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Wed, 19 Aug 2020 04:38:29 GMT

New page: '''Unreleased structure''' The entry 7a18 is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 7a18 is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

7a18 - Revision history

OCA at 12:01, 1 February 2024

OCA at 05:26, 6 October 2021

OCA: Protected "7a18" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 7a18 is ON HOLD Authors: Description: Category: Unreleased Structures